Big Moving Stock keep track of the biggest moving stocks in the market.
The Hot Industries
Independent Oil & Gas 5
Oil & Gas Drilling & Exploration 3
Diversified Machinery 2
The Hot Sectors
Basic Materials 11
Industrial Goods 2
JNJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and womens health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSONS, AVEENO, CLEAN & CLEAR, DABAO, JOHNSONS Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; blood glucose monitoring and insulin delivery products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Dow 30 Stock Roundup: JNJ Beats, JPM Disappoints17 Apr 2014, 7:46 amThe Dow notched up substantial gains during a holiday shortened week, boosted by several positive factors.
Will This Price Target Increase Help Johnson & Johnson (JNJ) Stock Today?16 Apr 2014, 8:18 amNEW YORK (TheStreet) -- Leerink increased its price target on Johnson & Johnson to $110, increased its estimates and set an "outperform" rating. The firm cited solid pharma momentum as the reason for the increase. The stock was flat at $99.24 at 9:52 a.m. on Wednesday. Must Read: Warren Buffett's 10 Favorite Growth Stocks STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks ...
Jim Cramer: Why Johnson & Johnson (JNJ) and Coca-Cola (KO) Reported Surprising Results15 Apr 2014, 10:18 amNEW YORK (TheStreet) -- TheStreet's Jim Cramer adds Johnson & Johnson and Coca-Cola to the list of big-cap companies that have reported surprising earnings recently. The stocks join Alcoa , Citigroup and Wells Fargo . Johnson & Johnson had a strong pharma number of +10, or +12 before currency translation. Cramer was "blown away" by Coca-Cola's ability to turn on the marketing dollars and turn ...
Why Johnson & Johnson (JNJ) Stock Is Up Today15 Apr 2014, 8:23 amNEW YORK (TheStreet) -- Johnson & Johnson stock is gaining on Tuesday after the company reported first-quarter results and as it increased its full-year EPS targets. By midmorning, shares had added 1.8% to $98.89. Over the three months to March, the company reported earnings of $1.54 a share and revenue of $18.11 billion. Analysts surveyed by Thomson Reuters anticipated net income of $1.48 a ...
Will This Downgrade Hurt Johnson & Johnson (JNJ) Today?14 Apr 2014, 7:38 amNEW YORK (TheStreet) -- Johnson & Johnson has been downgraded to "hold" from "buy" with an $105 price target, Jefferies said Monday. The firm said though the company still has strong fundamentals, its current valuation is too high. Must Read: Warren Buffett's 10 Favorite Growth Stocks STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the ...
Analysts' Actions: JNJ MDT MSFT MA V14 Apr 2014, 6:30 amHere are today's top research calls.
Cramer: Johnson & Johnson (JNJ) Deal Will Lead to Huge Buyback1 Apr 2014, 9:19 amNEW YORK (TheStreet) -- TheStreet's Jim Cramer says Johnson & Johnson's deal to sell its Ortho-Clinical Diagnostics business to The Carlyle Group for $4 billion will lead to a buyback of "a huge amount of stock." Cramer says Johnson & Johnson CEO Alex Gorsky set expectations very low for the quarter and this deal was done perfectly so that the company can announce in conjunction with its ...
Weekly 52-Week Highs Highlight: MAR, JNJ, HAL, BHI31 Mar 2014, 8:55 amAccording to GuruFocus list of 52-week highs; Marriott International Inc., Johnson & Johnson, Halliburton Company and Baker Hughes Inc.
Why Johnson & Johnson (JNJ) Stock May Move Higher On Monday31 Mar 2014, 7:33 amNEW YORK (TheStreet) -- Shares of Johnson & Johnson may advance today after the Wall Street Journal reported this morning that the company had accepted Carlyle Group's bid to acquire its ortho-clinical diagnostics business for nearly $4 billion. The shares are up 0.37% to 97.80 in premarket trade. The ortho-clinical diagnostics business provides in vitro diagnostic products, transfusion donor ...
One Put, One Call Option To Know About for Johnson & Johnson24 Mar 2014, 10:30 amConsistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call contract, from the June expiration for JNJ.